{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:30:54Z","timestamp":1787884254345,"version":"build-2784847793"},"reference-count":42,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Neutrophils are critical immune cells in severe coronavirus disease 2019 (COVID-19). S100 calcium-binding protein A12 (S100A12) is highly expressed in neutrophils during acute inflammation. The aim of this study was to evaluate serum S100A12 levels as a diagnostic and prognostic tool in COVID-19. Serum samples of patients with moderate and severe COVID-19 were collected during 2020 to 2024. Enzyme-linked immunosorbent assay was used to measure serum S100A12 levels in 63 patients with moderate COVID-19, 60 patients with severe disease and 33 healthy controls. Serum S100A12 levels were elevated in moderate COVID-19 compared to controls and were even higher in severe cases. In moderate disease, serum S100A12 levels positively correlated with immune cell counts. While C-reactive protein and procalcitonin are established inflammation markers, they did not correlate with serum S100A12 levels in either patient cohort. Patients with severe COVID-19 and vancomycin-resistant enterococcus (VRE) infection had increased S100A12 levels. Elevated S100A12 levels were also observed in patients with herpes simplex reactivation. Fungal superinfections did not alter S100A12 levels. These data show that serum S100A12 increases in moderate and severe COVID-19 and is further elevated by VRE bloodstream infection and herpes simplex reactivation. Therefore, S100A12 may serve as a novel biomarker for severe COVID-19 and an early diagnostic indicator for bacterial and viral infections.<\/jats:p>","DOI":"10.3390\/v16071084","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T12:30:59Z","timestamp":1720182659000},"page":"1084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19"],"prefix":"10.3390","volume":"16","author":[{"given":"Patricia","family":"Mester","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kunst","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"R\u00e4th","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Rusch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-2926","authenticated-orcid":false,"given":"Stephan","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-3509","authenticated-orcid":false,"given":"Vlad","family":"Pavel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Borges do Nascimento, I.J., Cacic, N., Abdulazeem, H.M., von Groote, T.C., Jayarajah, U., Weerasekara, I., Esfahani, M.A., Civile, V.T., Marusic, A., and Jeroncic, A. (2020). Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040941"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Georgieva, E., Ananiev, J., Yovchev, Y., Arabadzhiev, G., Abrashev, H., Abrasheva, D., Atanasov, V., Kostandieva, R., Mitev, M., and Petkova-Parlapanska, K. (2023). COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914876"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12985-023-02116-w","article-title":"Neutrophils in COVID-19: Recent insights and advances","volume":"20","author":"Li","year":"2023","journal-title":"Virol. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"McKenna, E., Wubben, R., Isaza-Correa, J.M., Melo, A.M., Mhaonaigh, A.U., Conlon, N., O\u2019Donnell, J.S., Ni Cheallaigh, C., Hurley, T., and Stevenson, N.J. (2022). Neutrophils in COVID-19: Not Innocent Bystanders. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.864387"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00726-008-0097-7","article-title":"Human S100A12: A novel key player in inflammation?","volume":"36","author":"Pietzsch","year":"2009","journal-title":"Amino Acids"},{"key":"ref_6","first-page":"907078","article-title":"The role of S100A12 as a systemic marker of inflammation","volume":"2012","author":"Meijer","year":"2012","journal-title":"Int. J. Inflam."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13035","DOI":"10.1074\/jbc.M710388200","article-title":"Mast cell and monocyte recruitment by S100A12 and its hinge domain","volume":"283","author":"Yan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2020.03.022","article-title":"S100A12 promotes inflammation and cell apoptosis in sepsis-induced ARDS via activation of NLRP3 in fl ammasome signaling","volume":"122","author":"Zhang","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1039\/C5SC03655K","article-title":"Calcium Ions Tune the Zinc-Sequestering Properties and Antimicrobial Activity of Human S100A12","volume":"7","author":"Cunden","year":"2016","journal-title":"Chem. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Roy, S., Bhogapurapu, B., Chandra, S., Biswas, K., Mishra, P., Ghosh, A., and Bhunia, A. (2024). Host antimicrobial peptide S100A12 disrupts the fungal membrane by direct binding and inhibits growth and biofilm formation of Fusarium species. J. Biol. Chem., 300.","DOI":"10.1016\/j.jbc.2024.105701"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Realegeno, S., Kelly-Scumpia, K.M., Dang, A.T., Lu, J., Teles, R., Liu, P.T., Schenk, M., Lee, E.Y., Schmidt, N.W., and Wong, G.C. (2016). S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005705"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijid.2021.02.112","article-title":"A host-based two-gene model for the identification of bacterial infection in general clinical settings","volume":"105","author":"Lei","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Jiang, X., Huang, C.M., Feng, C.M., Xu, Z., Fu, L., and Wang, X.M. (2021). Associations of Serum S100A12 With Severity and Prognosis in Patients with Community-Acquired Pneumonia: A Prospective Cohort Study. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.714026"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/INF.0b013e31824672cb","article-title":"Clinical significance of serum S100A12 in acute otitis media in young children","volume":"31","author":"Liu","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/01.CCM.0000262386.32287.29","article-title":"Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome","volume":"35","author":"Wittkowski","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lei, H. (2023). A two-gene marker for the two-tiered innate immune response in COVID-19 patients. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0280392"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28336","DOI":"10.1073\/pnas.2018030117","article-title":"Transcriptional and proteomic insights into the host response in fatal COVID-19 cases","volume":"117","author":"Wu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/joim.13725","article-title":"Circulating markers of extracellular matrix remodelling in severe COVID-19 patients","volume":"294","author":"Murphy","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study","volume":"27","author":"Sanjuan","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zsichla, L., and Muller, V. (2023). Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses, 15.","DOI":"10.3390\/v15010175"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s11845-021-02714-z","article-title":"Herpes simplex and herpes zoster viruses in COVID-19 patients","volume":"191","author":"Katz","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.1995.03520260077036","article-title":"Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS) Gulliver in Laputa","volume":"273","author":"Bone","year":"1995","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_25","unstructured":"(2024, July 03). Available online: https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","article-title":"Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis","volume":"49","author":"Karakike","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1038\/s41598-021-91754-7","article-title":"A single transcript for the prognosis of disease severity in COVID-19 patients","volume":"11","author":"Lei","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105654","DOI":"10.1016\/j.micpath.2022.105654","article-title":"Antimicrobial peptide S100A12 (calgranulin C) inhibits growth, biofilm formation, pyoverdine secretion and suppresses type VI secretion system in Pseudomonas aeruginosa","volume":"169","author":"Mishra","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S2666-5247(22)00355-X","article-title":"Antimicrobial resistance in patients with COVID-19: A systematic review and meta-analysis","volume":"4","author":"Langford","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: Global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13596535211068613","DOI":"10.1177\/13596535211068613","article-title":"Herpes simplex virus reactivation in patients with COVID-19 and acute respiratory distress syndrome: A prospective cohort study","volume":"27","author":"Chiesa","year":"2022","journal-title":"Antivir. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.23950\/jcmk\/9267","article-title":"Varicella-Zoster Virus Reactivation amid the COVID-19 pandemic- Do we need to be vigilant? A mini review","volume":"6","author":"Siddiqui","year":"2020","journal-title":"J. Clin. Med. Kazakhstan"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Katsikas Triantafyllidis, K., Giannos, P., Mian, I.T., Kyrtsonis, G., and Kechagias, K.S. (2021). Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports. Vaccines, 9.","DOI":"10.3390\/vaccines9091013"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ofae287","DOI":"10.1093\/ofid\/ofae287","article-title":"Varicella-Zoster Virus-Induced Neurologic Disease after COVID-19 Vaccination: A Multicenter Observational Cohort Study","volume":"11","author":"Elbaz","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/00365513.2021.1894601","article-title":"Platelet parameters and leukocyte morphology is altered in COVID-19 patients compared to non-COVID-19 patients with similar symptomatology","volume":"81","author":"Alnor","year":"2021","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jha2.44","article-title":"Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells","volume":"1","author":"Luke","year":"2020","journal-title":"EJHaem"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/s41467-023-37567-w","article-title":"Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rutkowska, E., Kwiecien, I., Pietruszka-Waleka, E., Wiesik-Szewczyk, E., Rzepecki, P., and Jahnz-Rozyk, K. (2023). Analysis of Leukocyte Subpopulations by Flow Cytometry during Hospitalization Depending on the Severity of COVID-19 Course. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102728"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Palladino, M. (2021). Complete blood count alterations in COVID-19 patients: A narrative review. Biochem. Med., 31.","DOI":"10.11613\/BM.2021.030501"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Guo, Y., Li, T., Xia, X., Su, B., Li, H., Feng, Y., Han, J., Wang, X., Jia, L., and Bao, Z. (2021). Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.723585"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zirou, C., Gumeni, S., Bellos, I., Ntanasis-Stathopoulos, I., Sklirou, A.D., Bagratuni, T., Korompoki, E., Apostolakou, F., Papassotiriou, I., and Trougakos, I.P. (2023). Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study. Viruses, 15.","DOI":"10.3390\/v15112250"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:10:51Z","timestamp":1760109051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["v16071084"],"URL":"https:\/\/doi.org\/10.3390\/v16071084","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}